The mechanism of granulopoiesis and leukemogenesis by the activation of Stat3
The mechanism of granulopoiesis and leukemogenesis by the activation of Stat3
批准号:
15390302
负责人:
SHIMODA Kazuya
金额:
$7.94万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Jak-Stat pathway plays an essential role in cytokine signaling. G-CSF promotes granulopoiesis, and Stat3 is the principle Stat protein activated by G-CSF. Upon treatment with G-CSF, the IL-3 dependent cell line 32D clone 3(32Dcl3) differentiates into neutrophils, and 32Dcl3 cells expressing dominant-negative Stat3 (32Dcl3/DNStat3) proliferate in G-CSF without differentiation. Gene expression profile of G-CSF-stimulated cell lines revealed that the expression of C/EBP_α was up-regulated by the activation of Stat3. And activated Stat3 bound to C/EBP_α, leading to the enhancement of the transcription activity of C/EBP_α. Conditional expression of C/EBP_α in 32Dcl3/DNStat3 cells after G-CSF stimulation abolishes the G-CSF dependent cell proliferation and induces granulocytic differentiation. These results show that one of the major roles of Stat3 in G-CSF signaling pathway is to augment the function of C/EBP_α.The function of Stat3 in vivo was examined using the Stat3 conditional deficient mice. Mice deficient for Stat3 in hematopoietic cells show neutrocytosis, and G-CSF-induced proliferation of progenitor cells was observed in Stat3-deficient mice. In hematopoietic cells from Stat3-deficient mice, trace levels of SOCS3, a negative regulator of granulopoiesis, were observed, and SOCS3 expression was not induced by G-CSF stimulation. Stat3 null bone marrow cells displayed a significant activation of ERK1/2 under basal conditions, and it was enhanced and sustained by G-CSF stimulation. Furthermore, the augmented proliferation of Stat3-deficient bone marrow cells in response to G-CSF was dramatically decreased by addition of a MEK1 inhibitor. Stat3 functions in vivo as a negative regulator of G-CSF signaling by inducing SOCS3 expression, and ERK activation is the major factor responsible for inducing the proliferation of hematopoietic cells in response to G-CSF.
期刊论文(81)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Physical and functional interactions between Daxx and DNA methyltransferase1 associated protein, DMAP.
Daxx 和 DNA 甲基转移酶 1 相关蛋白 (DMAP) 之间的物理和功能相互作用。
DOI:
--
发表时间:
2004
期刊:
J Immunol 172
影响因子:
--
作者:
[Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M, Muromoto R]
通讯作者:
Muromoto R
Tyk2 interacts with and phosphorylates Rack-1, a WD motif containing protein.
Tyk2 与 Rack-1(一种含有 WD 基序的蛋白质)相互作用并使其磷酸化。
DOI:
--
发表时间:
2004
期刊:
J Immunol 173
影响因子:
--
作者:
[Haro T]
通讯作者:
Haro T
Seto Y, Nakajima H, Suto A, Shimoda K, et al.: "Enhanced Th2 Cell-mediated Allergic Inflammation in Tyk2-deficient Mice."Journal of Immunology. 170. 1077-1083 (2003)
Seto Y、Nakajima H、Suto A、Shimoda K 等人:“Tyk2 缺陷小鼠中 Th2 细胞介导的过敏性炎症增强。”免疫学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth.
干扰素的细胞内信号转导抑制造血祖细胞生长。
DOI:
--
发表时间:
2003
期刊:
Br J Haematol 123
影响因子:
--
作者:
[Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M, Muromoto R, Muromoto R, Kamezaki K, Seto Y, Muromoto R, Kamezaki K, Kato K]
通讯作者:
Kato K
Transgenic Mice Overexpressing Murine Thrombopoietin Develop Myelofibosis and Osteosclerosis.
过度表达鼠类血小板生成素的转基因小鼠会出现骨髓纤维化和骨硬化。
DOI:
--
发表时间:
期刊:
Leukemia Research (印刷中)
影响因子:
--
作者:
[K, Sekine Y, Ouchi Y, Takei N, Minabe Y et al., Kakumitsu H]
通讯作者:
Kakumitsu H
共 29 条
The mechanism of polycythemia vera and essential thrombocythemia
-
批准号:20591137
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:SHIMODA Kazuya
-
依托单位:
The intracellular signal transduction of granulopoiesis
-
批准号:11307015
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.33万
-
财政年份:1999
-
负责人:SHIMODA Kazuya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
STAT3/C/EBPD-SLC5A12生物轴调控内质网应激相关蛋白乳酸化修饰在脓毒症急性肺损伤中的作用及机制研究
-
批准号:JCZRLH202602096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RGS5通过c-Myc/STAT3途径调控PD-L1进而抑制免疫细胞浸润导致胃癌免疫治疗抵抗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨震伟
-
依托单位:
C5a/C5aR1/SphK1/TRAF6信号轴通过调控STAT3泛素化降解诱导铁死亡促进脓毒症肺损伤的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:戚芹瑶
-
依托单位:
补体通路C3a/C3ar1/STAT3调控Pla2g5介导巨噬细胞-肌成纤维细胞转化在骨骼肌急性损伤后纤维化
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙亚英
-
依托单位:
Jmjd1c通过促进STAT3去甲基化抑制B细胞分化在原发性干
燥综合征发病中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
NSUN2 通过m5C 修饰调控 STAT3 促进下咽鳞癌 PD-L1 的表达的机制研究
-
批准号:24ZR1458700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙臻峰
-
依托单位:
重离子(12C6+)辐射通过IL-6/JAK2/STAT3途径调控NKG2D-Ls和FOXP3双靶点增强NK细胞活性的机制研究
-
批准号:82360583
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:冉俊涛
-
依托单位:
FABP4+C1q+巨噬细胞通过重塑脂肪酸代谢诱导AMPK去磷酸化增强JAK2/STAT3正反馈通路的抗肺癌机制
-
批准号:82372779
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:任秀宝
-
依托单位:
RET基因M918T突变通过JAK/STAT3信号通路轴调控腱糖蛋白C表达促进甲状腺髓样癌细胞干性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史潇
-
依托单位:
HGF/c-Met/STAT3信号对GMSC调控树突状细胞改善过敏性哮喘的作用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:方倩楠
-
依托单位: